Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neoplasms of the CNS

  Free Subscription


Articles published in J Neurosurg

Retrieve available abstracts of 140 articles:
HTML format



Single Articles


    October 2021
  1. MOMIN AA, Soni P, Shao J, Nowacki AS, et al
    Adjuvant radiation versus observation with salvage radiation after gross-total resection of WHO grade II meningiomas: a propensity score-adjusted analysis.
    J Neurosurg. 2021 Oct 8:1-8. doi: 10.3171/2021.4.JNS21559.
    PubMed     Abstract available


  2. SCHUPPER AJ, Baron RB, Cheung W, Rodriguez J, et al
    5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
    J Neurosurg. 2021 Oct 8:1-10. doi: 10.3171/2021.5.JNS21310.
    PubMed     Abstract available


  3. POPADIC B, Scheichel F, Pinggera D, Weber M, et al
    The meningioma surface factor: a novel approach to quantify shape irregularity on preoperative imaging and its correlation with WHO grade.
    J Neurosurg. 2021 Oct 8:1-7. doi: 10.3171/2021.5.JNS204223.
    PubMed     Abstract available


  4. DUFFAU H
    Introducing the concept of brain metaplasticity in glioma: how to reorient the pattern of neural reconfiguration to optimize the therapeutic strategy.
    J Neurosurg. 2021 Oct 8:1-5. doi: 10.3171/2021.5.JNS211214.
    PubMed    


  5. YOUNG JS, Gogos AJ, Aabedi AA, Morshed RA, et al
    Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract.
    J Neurosurg. 2021 Oct 1:1-7. doi: 10.3171/2021.4.JNS21187.
    PubMed     Abstract available


  6. FISHER FL, Zamanipoor Najafabadi AH, van der Meer PB, Boele FW, et al
    Long-term health-related quality of life and neurocognitive functioning after treatment in skull base meningioma patients.
    J Neurosurg. 2021 Oct 1:1-13. doi: 10.3171/2021.4.JNS203891.
    PubMed     Abstract available


    September 2021
  7. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Awake craniotomy with transcortical motor evoked potential monitoring for resection of gliomas within or close to motor-related areas: validation of utility for predicting motor function.
    J Neurosurg. 2021 Sep 24:1-10. doi: 10.3171/2021.3.JNS21374.
    PubMed     Abstract available


  8. MEDIKONDA R, Patel K, Jackson C, Saleh L, et al
    The safety and efficacy of dexamethasone in the perioperative management of glioma patients.
    J Neurosurg. 2021 Sep 24:1-8. doi: 10.3171/2021.4.JNS204127.
    PubMed     Abstract available


  9. ASUZU DT, Bunevicius A, Kormath Anand R, Suleiman M, et al
    Clinical and radiologic outcomes after stereotactic radiosurgery for meningiomas in direct contact with the optic apparatus: an international multicenter study.
    J Neurosurg. 2021 Sep 24:1-7. doi: 10.3171/2021.3.JNS21328.
    PubMed     Abstract available


  10. HAMDAN N, Duffau H
    Extending the multistage surgical strategy for recurrent initially low-grade gliomas: functional and oncological outcomes in 31 consecutive patients who underwent a third resection under awake mapping.
    J Neurosurg. 2021 Sep 10:1-10. doi: 10.3171/2021.3.JNS21264.
    PubMed     Abstract available


  11. CARNEVALE JA, Imber BS, Winston GM, Goldberg JL, et al
    Risk of tract recurrence with stereotactic biopsy of brain metastases: an 18-year cancer center experience.
    J Neurosurg. 2021 Sep 10:1-7. doi: 10.3171/2021.3.JNS204347.
    PubMed     Abstract available


    August 2021
  12. SHIMIZU Y, Gumin J, Gao F, Hossain A, et al
    Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
    J Neurosurg. 2021 Aug 27:1-11. doi: 10.3171/2021.3.JNS203045.
    PubMed     Abstract available


  13. MORSHED RA, Jiam NT, Wang EJ, Magill ST, et al
    Posterior petrous face meningiomas presenting with Meniere's-like syndrome: a case series and review of the literature.
    J Neurosurg. 2021 Aug 27:1-8. doi: 10.3171/2021.2.JNS203259.
    PubMed     Abstract available


  14. BENJAMIN CG, Schnurman Z, Ashayeri K, Kazi E, et al
    Volumetric growth rates of untreated cavernous sinus meningiomas.
    J Neurosurg. 2021 Aug 20:1-8. doi: 10.3171/2021.2.JNS203485.
    PubMed     Abstract available


  15. MEDIKONDA R, Choi J, Pant A, Saleh L, et al
    Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
    J Neurosurg. 2021 Aug 13:1-10. doi: 10.3171/2021.1.JNS202482.
    PubMed     Abstract available


  16. SPINA A, Boari N, Mortini P
    Letter to the Editor. Management of hyperostotic spheno-orbital meningiomas.
    J Neurosurg. 2021 Aug 13:1-2. doi: 10.3171/2021.4.JNS21952.
    PubMed    


  17. CHUANG JM, Hueng DY
    Letter to the Editor. Treatment of MGMT-positive glioblastoma.
    J Neurosurg. 2021 Aug 6:1. doi: 10.3171/2021.3.JNS21571.
    PubMed    


  18. ROMERO-GARCIA R, Suckling J, Owen M, Assem M, et al
    Memory recovery in relation to default mode network impairment and neurite density during brain tumor treatment.
    J Neurosurg. 2021 Aug 6:1-11. doi: 10.3171/2021.1.JNS203959.
    PubMed     Abstract available


    July 2021
  19. AMMANUEL SG, Almeida NC, Kurteff G, Kakaizada S, et al
    Correlation of natural language assessment results with health-related quality of life in adult glioma patients.
    J Neurosurg. 2021 Jul 30:1-7. doi: 10.3171/2021.1.JNS203387.
    PubMed     Abstract available


  20. LAD M, Gupta R, Raman A, Parikh N, et al
    Trends in physician reimbursements and procedural volumes for radiosurgery versus open surgery in brain tumor care: an analysis of Medicare data from 2009 to 2018.
    J Neurosurg. 2021 Jul 30:1-12. doi: 10.3171/2020.11.JNS202284.
    PubMed     Abstract available


  21. HAMIDI N, Karmur B, Sperrazza S, Alexieva J, et al
    Guidelines for optimal utilization of social media for brain tumor stakeholders.
    J Neurosurg. 2021 Jul 23:1-8. doi: 10.3171/2020.11.JNS203226.
    PubMed     Abstract available


  22. ULGEN E, Aras FK, Cosgun E, Ersen-Danyeli A, et al
    Correlation of anatomical involvement patterns of insular gliomas with subnetworks of the limbic system.
    J Neurosurg. 2021 Jul 23:1-12. doi: 10.3171/2020.12.JNS203652.
    PubMed     Abstract available


  23. ASANO K, Hasegawa S, Matsuzaka M, Ohkuma H, et al
    Brain tumor-related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data.
    J Neurosurg. 2021 Jul 16:1-12. doi: 10.3171/2020.11.JNS202873.
    PubMed     Abstract available


  24. NEMAN J, Franklin M, Madaj Z, Deshpande K, et al
    Use of predictive spatial modeling to reveal that primary cancers have distinct central nervous system topography patterns of brain metastasis.
    J Neurosurg. 2021 Jul 16:1-9. doi: 10.3171/2021.1.JNS203536.
    PubMed     Abstract available


  25. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    J Neurosurg. 2021 Jul 9:1-11. doi: 10.3171/2020.11.JNS202897.
    PubMed     Abstract available


  26. LI L, Fang S, Li G, Zhang K, et al
    Glioma-related epilepsy in patients with diffuse high-grade glioma after the 2016 WHO update: seizure characteristics, risk factors, and clinical outcomes.
    J Neurosurg. 2021 Jul 9:1-9. doi: 10.3171/2020.12.JNS203351.
    PubMed     Abstract available


  27. CHAN AY, Choi EH, Oh MY, Vadera S, et al
    Elective versus nonelective brain tumor resections: a 5-year propensity score matching cost comparison analysis.
    J Neurosurg. 2021 Jul 9:1-5. doi: 10.3171/2020.12.JNS203401.
    PubMed     Abstract available


    June 2021
  28. ROSSI M, Puglisi G, Conti Nibali M, Vigano L, et al
    Asleep or awake motor mapping for resection of perirolandic glioma in the nondominant hemisphere? Development and validation of a multimodal score to tailor the surgical strategy.
    J Neurosurg. 2021 Jun 18:1-14. doi: 10.3171/2020.11.JNS202715.
    PubMed     Abstract available


  29. MOHAMMED N, Hung YC, Xu Z, Chytka T, et al
    Neurofibromatosis type 2-associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery.
    J Neurosurg. 2021 Jun 18:1-6. doi: 10.3171/2020.12.JNS202814.
    PubMed     Abstract available


  30. KANEKO S, Suero Molina E, Sporns P, Schipmann S, et al
    Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
    J Neurosurg. 2021 Jun 18:1-7. doi: 10.3171/2020.10.JNS202881.
    PubMed     Abstract available


  31. SHAH PP, Franke JL, Medikonda R, Jackson CM, et al
    Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
    J Neurosurg. 2021 Jun 4:1-11. doi: 10.3171/2020.10.JNS201787.
    PubMed     Abstract available


  32. DELLA PEPA GM, D'Alessandris QG, Burattini B, Quaranta D, et al
    Letter to the Editor. Exploring cognitive functions in low-grade glioma surgery.
    J Neurosurg. 2021 Jun 4:1-2. doi: 10.3171/2021.2.JNS21186.
    PubMed    


  33. VIVAS-BUITRAGO T, Domingo RA, Tripathi S, De Biase G, et al
    Influence of supramarginal resection on survival outcomes after gross-total resection of IDH-wild-type glioblastoma.
    J Neurosurg. 2021 Jun 4:1-8. doi: 10.3171/2020.10.JNS203366.
    PubMed     Abstract available


    May 2021
  34. ROTH O'BRIEN DA, Kaye SM, Poppas PJ, Mahase SS, et al
    Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis.
    J Neurosurg. 2021 May 28:1-11. doi: 10.3171/2020.10.JNS201934.
    PubMed     Abstract available


  35. BABA A, Saha A, McCradden MD, Boparai K, et al
    Development and validation of a patient-centered, meningioma-specific quality-of-life questionnaire.
    J Neurosurg. 2021 May 14:1-10. doi: 10.3171/2020.11.JNS201761.
    PubMed     Abstract available


  36. QIAO N, Yang X, Li C, Ma G, et al
    The predictive value of intraoperative visual evoked potential for visual outcome after extended endoscopic endonasal surgery for adult craniopharyngioma.
    J Neurosurg. 2021 May 7:1-11. doi: 10.3171/2020.10.JNS202779.
    PubMed     Abstract available


    March 2021
  37. FAN J, Liu Y, Pan J, Peng Y, et al
    Endoscopic endonasal versus transcranial surgery for primary resection of craniopharyngiomas based on a new QST classification system: a comparative series of 315 patients.
    J Neurosurg. 2021 Mar 5:1-12. doi: 10.3171/2020.7.JNS20257.
    PubMed     Abstract available


  38. MAGILL ST, Jane JA, Prevedello DM
    Editorial. Craniopharyngioma classification.
    J Neurosurg. 2021 Mar 5:1-3. doi: 10.3171/2020.8.JNS202666.
    PubMed    


  39. FONSECA A, Solano P, Ramaswamy V, Tabori U, et al
    Ventricular size determination and management of ventriculomegaly and hydrocephalus in patients with diffuse intrinsic pontine glioma: an institutional experience.
    J Neurosurg. 2021 Mar 5:1-7. doi: 10.3171/2020.10.JNS203257.
    PubMed     Abstract available


  40. TENG CW, Cho SS, Singh Y, De Ravin E, et al
    Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgery.
    J Neurosurg. 2021 Mar 2:1-10. doi: 10.3171/2020.8.JNS201810.
    PubMed     Abstract available


    February 2021
  41. MORISAKO H, Ohata H, Shinde B, Nagahama A, et al
    Minimal anterior and posterior combined transpetrosal approach for large petroclival meningiomas.
    J Neurosurg. 2021 Feb 19:1-10. doi: 10.3171/2020.8.JNS202060.
    PubMed     Abstract available


  42. RAPOPORT BI, McDermott MW, Schwartz TH
    Letter to the Editor. Time to move beyond the Simpson scale in meningioma surgery.
    J Neurosurg. 2021 Feb 19:1-2. doi: 10.3171/2020.12.JNS204213.
    PubMed    


    January 2021
  43. MAGILL ST, Nguyen MP, Aghi MK, Theodosopoulos PV, et al
    Postoperative diffusion-weighted imaging and neurological outcome after convexity meningioma resection.
    J Neurosurg. 2021 Jan 29:1-8. doi: 10.3171/2020.8.JNS193537.
    PubMed     Abstract available


  44. MOTOMURA K, Chalise L, Shimizu H, Yamaguchi J, et al
    Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery.
    J Neurosurg. 2021 Jan 22:1-10. doi: 10.3171/2020.8.JNS201400.
    PubMed     Abstract available


  45. YOUNG JS, Gogos AJ, Pereira MP, Morshed RA, et al
    Effects of ventricular entry on patient outcome during glioblastoma resection.
    J Neurosurg. 2021 Jan 8:1-9. doi: 10.3171/2020.7.JNS201362.
    PubMed     Abstract available


  46. BUNEVICIUS A, Suleiman M, Patel S, Martinez Alvarez R, et al
    Stereotactic radiosurgery for treatment of radiation-induced meningiomas: a multiinstitutional study.
    J Neurosurg. 2021 Jan 1:1-9. doi: 10.3171/2020.7.JNS202064.
    PubMed     Abstract available


    December 2020
  47. STOGBAUER L, Thomas C, Wagner A, Warneke N, et al
    Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT.
    J Neurosurg. 2020 Dec 11:1-10. doi: 10.3171/2020.7.JNS193097.
    PubMed     Abstract available


  48. KENNEDY WR, DeWees TA, Acharya S, Mahmood M, et al
    Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2020 Dec 11:1-7. doi: 10.3171/2020.7.JNS192210.
    PubMed     Abstract available


  49. GUPTE TP, Li C, Jin L, Yalcin K, et al
    Clinical and genomic factors associated with seizures in meningiomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201042.
    PubMed     Abstract available


  50. NG S, Herbet G, Lemaitre AL, Cochereau J, et al
    Neuropsychological assessments before and after awake surgery for incidental low-grade gliomas.
    J Neurosurg. 2020 Dec 4:1-10. doi: 10.3171/2020.7.JNS201507.
    PubMed     Abstract available


    November 2020
  51. GOGOS AJ
    Erratum. Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Nov 27:1. doi: 10.3171/2020.10.JNS193434.
    PubMed    


  52. YOO DH, Sohn CH, Cho YD, Kang HS, et al
    Superselective pseudocontinuous arterial spin labeling in patients with meningioma: utility in prediction of feeding arteries and preoperative embolization feasibility.
    J Neurosurg. 2020 Nov 13:1-7. doi: 10.3171/2020.7.JNS201915.
    PubMed     Abstract available


  53. MIYOSHI K, Wada T, Uwano I, Sasaki M, et al
    Predicting the consistency of intracranial meningiomas using apparent diffusion coefficient maps derived from preoperative diffusion-weighted imaging.
    J Neurosurg. 2020 Nov 13:1-8. doi: 10.3171/2020.6.JNS20740.
    PubMed     Abstract available


    October 2020
  54. PRZYBYLOWSKI CJ, Hendricks BK, Frisoli FA, Zhao X, et al
    Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience.
    J Neurosurg. 2020 Oct 23:1-9. doi: 10.3171/2020.6.JNS20374.
    PubMed     Abstract available


  55. CHICOINE MR, Yahanda AT, Dacey RG
    A tribute to the late Professor Donald Simpson, Australian neurosurgeon and namesake of the Simpson grading system for meningioma extent of resection.
    J Neurosurg. 2020 Oct 23:1-7. doi: 10.3171/2020.6.JNS201331.
    PubMed     Abstract available


  56. SHAH AS, Sylvester PT, Yahanda AT, Vellimana AK, et al
    Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
    J Neurosurg. 2020 Oct 9:1-10. doi: 10.3171/2020.6.JNS19287.
    PubMed     Abstract available


  57. SELLIER A, Moritz-Gasser S, Lemaitre AL, Herbet G, et al
    Presence of a translator in the operating theater for awake mapping in foreign patients with low-grade glioma: a surgical experience based on 18 different native languages.
    J Neurosurg. 2020 Oct 9:1-9. doi: 10.3171/2020.6.JNS201071.
    PubMed     Abstract available


  58. GOGOS AJ, Young JS, Pereira MP, Morshed RA, et al
    Surgical management of incidentally discovered low-grade gliomas.
    J Neurosurg. 2020 Oct 2:1-8. doi: 10.3171/2020.6.JNS201296.
    PubMed     Abstract available


  59. LIVERMORE LJ, Isabelle M, Bell IM, Edgar O, et al
    Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced fluorescence-guided surgery.
    J Neurosurg. 2020 Oct 2:1-11. doi: 10.3171/2020.5.JNS20376.
    PubMed     Abstract available


    September 2020
  60. NAVARRIA P, Pessina F, Clerici E, Rossini Z, et al
    Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series.
    J Neurosurg. 2020 Sep 4:1-14. doi: 10.3171/2020.5.JNS201116.
    PubMed     Abstract available


    August 2020
  61. WANG L, Chen J
    Letter to the Editor. Feasibility and safety of supratotal resection for low-grade gliomas.
    J Neurosurg. 2020 Aug 28:1-2. doi: 10.3171/2020.7.JNS202601.
    PubMed    


  62. KHALAFALLAH AM, Huq S, Jimenez AE, Brem H, et al
    The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients.
    J Neurosurg. 2020 Aug 14:1-9. doi: 10.3171/2020.5.JNS20766.
    PubMed     Abstract available


    July 2020
  63. STRICKLAND BA, Wedemeyer M, Sizdahkhani S, Giannotta SL, et al
    Letter to the Editor. Management of petroclival meningioma.
    J Neurosurg. 2020 Jul 31:1-3. doi: 10.3171/2020.3.JNS20599.
    PubMed    


  64. YOUNGERMAN BE, Banu MA, Gerges MM, Odigie E, et al
    Endoscopic endonasal approach for suprasellar meningiomas: introduction of a new scoring system to predict extent of resection and assist in case selection with long-term outcome data.
    J Neurosurg. 2020 Jul 24:1-13. doi: 10.3171/2020.4.JNS20475.
    PubMed     Abstract available


  65. FUKUI N, Yawata T, Nakajo T, Kawanishi Y, et al
    Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
    J Neurosurg. 2020 Jul 24:1-11. doi: 10.3171/2020.4.JNS193078.
    PubMed     Abstract available


  66. SPILLE DC, Hess K, Bormann E, Sauerland C, et al
    Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification.
    J Neurosurg. 2020 Jul 17:1-8. doi: 10.3171/2020.4.JNS20412.
    PubMed     Abstract available


  67. BUNEVICIUS A, Lavezzo K, Shabo L, McClure J, et al
    Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
    J Neurosurg. 2020 Jul 10:1-9. doi: 10.3171/2020.4.JNS20788.
    PubMed     Abstract available


    June 2020
  68. TAKAMI H, Khoshnood N, Bernstein M
    Preoperative factors associated with adverse events during awake craniotomy: analysis of 609 consecutive cases.
    J Neurosurg. 2020 Jun 26:1-9. doi: 10.3171/2020.4.JNS20378.
    PubMed     Abstract available


  69. ANSARI A
    Letter to the Editor. Awake craniotomy and transcortical MEP monitoring for resection of precentral gliomas.
    J Neurosurg. 2020 Jun 12:1-2. doi: 10.3171/2020.4.JNS201190.
    PubMed    


  70. CHAICHANA KL
    Erratum. Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jun 12:1. doi: 10.3171/2020.5.JNS192466.
    PubMed    


  71. SUI R, Piao H
    Letter to the Editor. Residual meningiomas.
    J Neurosurg. 2020 Jun 12:1-3. doi: 10.3171/2020.2.JNS20447.
    PubMed    


  72. GOGOS AJ, Young JS, Morshed RA, Avalos LN, et al
    Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways.
    J Neurosurg. 2020 Jun 5:1-10. doi: 10.3171/2020.3.JNS193434.
    PubMed     Abstract available


  73. GARTON ALA, Kinslow CJ, Wang TJC
    Erratum. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 Jun 5:1. doi: 10.3171/2020.5.JNS192767.
    PubMed    


  74. KONG DS, Kim YH, Hong CK
    Optimal indications and limitations of endoscopic transorbital superior eyelid surgery for spheno-orbital meningiomas.
    J Neurosurg. 2020 Jun 5:1-8. doi: 10.3171/2020.3.JNS20297.
    PubMed     Abstract available


    May 2020
  75. YOUNG JS, Chan AK, Viner JA, Sankaran S, et al
    A Safe Transitions Pathway for post-craniotomy neurological surgery patients: high-value care that bypasses the intensive care unit.
    J Neurosurg. 2020 May 29:1-6. doi: 10.3171/2020.3.JNS192133.
    PubMed     Abstract available


  76. ABI JAOUDE S, Peyre M, Degos V, Goutagny S, et al
    Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.
    J Neurosurg. 2020 May 22:1-9. doi: 10.3171/2020.3.JNS192382.
    PubMed     Abstract available


  77. JULIE DA, Lazow SP, Vanderbilt DB, Taube S, et al
    A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    J Neurosurg. 2020 May 15:1-8. doi: 10.3171/2020.3.JNS193419.
    PubMed     Abstract available


  78. FATIMA N, Ding VY, Han SS, Chang SD, et al
    Predictors of visual functional outcome following treatment for cavernous sinus meningioma.
    J Neurosurg. 2020 May 15:1-12. doi: 10.3171/2020.2.JNS193009.
    PubMed     Abstract available


  79. BOWDEN GN, Kim JO, Faramand A, Fallon K, et al
    Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases.
    J Neurosurg. 2020 May 8:1-5. doi: 10.3171/2020.3.JNS193369.
    PubMed     Abstract available


  80. GARTON ALA, Kinslow CJ, Rae AI, Mehta A, et al
    Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    J Neurosurg. 2020 May 8:1-11. doi: 10.3171/2020.2.JNS192767.
    PubMed     Abstract available


  81. SAITO T, Muragaki Y, Tamura M, Maruyama T, et al
    Correlation between localization of supratentorial glioma to the precentral gyrus and difficulty in identification of the motor area during awake craniotomy.
    J Neurosurg. 2020 May 1:1-10. doi: 10.3171/2020.2.JNS193471.
    PubMed     Abstract available


  82. MIRCHANDANI AS, Beyh A, Lavrador JP, Howells H, et al
    Altered corticospinal microstructure and motor cortex excitability in gliomas: an advanced tractography and transcranial magnetic stimulation study.
    J Neurosurg. 2020 May 1:1-9. doi: 10.3171/2020.2.JNS192994.
    PubMed     Abstract available


    April 2020
  83. DE VRIES F
    Letter to the Editor. Cognitive performance of patients with low-grade glioma.
    J Neurosurg. 2020 Apr 24:1-2. doi: 10.3171/2020.1.JNS2097.
    PubMed    


  84. LEE AT, Faltermeier C, Morshed RA, Young JS, et al
    The impact of high functional connectivity network hub resection on language task performance in adult low- and high-grade glioma.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS192267.
    PubMed     Abstract available


  85. CHU S
    Erratum. Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2020 Apr 3:1. doi: 10.3171/2020.2.JNS191920.
    PubMed    


  86. MULLER DMJ, Robe PA, Ardon H, Barkhof F, et al
    Quantifying eloquent locations for glioblastoma surgery using resection probability maps.
    J Neurosurg. 2020 Apr 3:1-11. doi: 10.3171/2020.1.JNS193049.
    PubMed     Abstract available


  87. CARRION-PENAGOS J, Zeineddine HA, Polster SP, Girard R, et al
    Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
    J Neurosurg. 2020 Apr 3:1-8. doi: 10.3171/2020.1.JNS193479.
    PubMed     Abstract available


    March 2020
  88. PRZYBYLOWSKI CJ, Zhao X, Baranoski JF, Borba Moreira L, et al
    Preoperative embolization versus no embolization for WHO grade I intracranial meningioma: a retrospective matched cohort study.
    J Neurosurg. 2020 Mar 27:1-8. doi: 10.3171/2020.1.JNS19788.
    PubMed     Abstract available


  89. LOHMANN S, Brix T, Varghese J, Warneke N, et al
    Development and validation of prediction scores for nosocomial infections, reoperations, and adverse events in the daily clinical setting of neurosurgical patients with cerebral and spinal tumors.
    J Neurosurg. 2020 Mar 20:1-11. doi: 10.3171/2020.1.JNS193186.
    PubMed     Abstract available


  90. ZANELLO M, Roux A, Zah-Bi G, Trancart B, et al
    Predictors of early postoperative epileptic seizures after awake surgery in supratentorial diffuse gliomas.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2020.1.JNS192774.
    PubMed     Abstract available


  91. YAMADA T, Tsuji S, Nakamura S, Egashira Y, et al
    Riluzole enhances the antitumor effects of temozolomide via suppression of MGMT expression in glioblastoma.
    J Neurosurg. 2020 Mar 13:1-10. doi: 10.3171/2019.12.JNS192682.
    PubMed     Abstract available


  92. DALLE ORE CL, Magill ST, Rodriguez Rubio R, Shahin MN, et al
    Hyperostosing sphenoid wing meningiomas: surgical outcomes and strategy for bone resection and multidisciplinary orbital reconstruction.
    J Neurosurg. 2020 Mar 6:1-10. doi: 10.3171/2019.12.JNS192543.
    PubMed     Abstract available


    February 2020
  93. RUTLAND JW, Loewenstern J, Ranti D, Tsankova NM, et al
    Analysis of 7-tesla diffusion-weighted imaging in the prediction of pituitary macroadenoma consistency.
    J Neurosurg. 2020 Feb 28:1-9. doi: 10.3171/2019.12.JNS192940.
    PubMed     Abstract available


  94. GOLUB D, Hyde J, Dogra S, Nicholson J, et al
    Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis.
    J Neurosurg. 2020 Feb 21:1-15. doi: 10.3171/2019.12.JNS191203.
    PubMed     Abstract available


  95. ISHI Y, Yamaguchi S, Hatanaka KC, Okamoto M, et al
    Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    J Neurosurg. 2020 Feb 14:1-9. doi: 10.3171/2019.12.JNS192155.
    PubMed     Abstract available


  96. YAMASHITA D, Bernstock JD, Elsayed G, Sadahiro H, et al
    Targeting glioma-initiating cells via the tyrosine metabolic pathway.
    J Neurosurg. 2020 Feb 14:1-12. doi: 10.3171/2019.11.JNS192028.
    PubMed     Abstract available


  97. ALHILALI LM, Little AS, Yuen KCJ, Lee J, et al
    Early postoperative MRI and detection of residual adenoma after transsphenoidal pituitary surgery.
    J Neurosurg. 2020 Feb 7:1-10. doi: 10.3171/2019.11.JNS191845.
    PubMed     Abstract available


    January 2020
  98. SUERO MOLINA E, Brokinkel B
    Letter to the Editor. Sodium fluorescein versus 5-aminolevulinic acid to visualize high-grade gliomas.
    J Neurosurg. 2020 Jan 24:1-3. doi: 10.3171/2019.12.JNS193180.
    PubMed    


  99. SCHIPMANN S, Muther M, Stogbauer L, Zimmer S, et al
    Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control.
    J Neurosurg. 2020 Jan 24:1-11. doi: 10.3171/2019.11.JNS192443.
    PubMed     Abstract available


  100. PRIETO R, Pascual JM
    Cushing's dogged struggle against death: the astonishing case of a patient under cardiac arrest surviving craniopharyngioma surgery.
    J Neurosurg. 2020 Jan 17:1-10. doi: 10.3171/2019.11.JNS192487.
    PubMed     Abstract available


  101. LIU D, Chen J, Hu X, Hu G, et al
    Contralesional homotopic functional plasticity in patients with temporal glioma.
    J Neurosurg. 2020 Jan 10:1-9. doi: 10.3171/2019.11.JNS191982.
    PubMed     Abstract available


  102. MATERI J, Mampre D, Ehresman J, Rincon-Torroella J, et al
    Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection.
    J Neurosurg. 2020 Jan 3:1-7. doi: 10.3171/2019.10.JNS192466.
    PubMed     Abstract available


  103. PARK SH, Kim MJ, Jung HH, Chang WS, et al
    Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy.
    J Neurosurg. 2020 Jan 3:1-9. doi: 10.3171/2019.10.JNS192206.
    PubMed     Abstract available


    December 2019
  104. BERGER A, Tzarfati G, Costa M, Serafimova M, et al
    Incidence and impact of stroke following surgery for low-grade gliomas.
    J Neurosurg. 2019 Dec 27:1-9. doi: 10.3171/2019.10.JNS192301.
    PubMed     Abstract available


  105. RUSTEMI O, Raneri F, Beggio G, Volpin L, et al
    Letter to the Editor. Cost-effectiveness of sodium fluorescein in high-grade gliomas.
    J Neurosurg. 2019 Dec 13:1-2. doi: 10.3171/2019.10.JNS192817.
    PubMed    


  106. ARRIETA VA, Iwamoto F, Lukas RV, Sachdev S, et al
    Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?
    J Neurosurg. 2019 Dec 6:1-6. doi: 10.3171/2019.9.JNS192523.
    PubMed    


    November 2019
  107. TULEASCA C, Giammattei L, Daniel RT, Levivier M, et al
    Letter to the Editor. Multimodal management for benign skull base meningiomas.
    J Neurosurg. 2019 Nov 15:1-2. doi: 10.3171/2019.6.JNS191682.
    PubMed    


  108. QIU T, Chanchotisatien A, Qin Z, Wu J, et al
    Imaging characteristics of adult H3 K27M-mutant gliomas.
    J Neurosurg. 2019 Nov 15:1-9. doi: 10.3171/2019.9.JNS191920.
    PubMed     Abstract available


  109. RIJNEN SJM, Kaya G, Gehring K, Verheul JB, et al
    Cognitive functioning in patients with low-grade glioma: effects of hemispheric tumor location and surgical procedure.
    J Neurosurg. 2019 Nov 15:1-12. doi: 10.3171/2019.8.JNS191667.
    PubMed     Abstract available


  110. PRIETO R, Pascual JM, Barrios L
    Charles H. Frazier's craniopharyngioma treatment: the pivotal role of the transfrontal approach.
    J Neurosurg. 2019 Nov 8:1-14. doi: 10.3171/2019.8.JNS191508.
    PubMed     Abstract available


  111. BERNSTEIN A, Mrowczynski OD, Greene A, Ryan S, et al
    Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity.
    J Neurosurg. 2019 Nov 1:1-6. doi: 10.3171/2019.8.JNS19643.
    PubMed     Abstract available


  112. PRIETO R, Pascual JM
    Letter to the Editor. The craniopharyngioma-hypothalamus relationship.
    J Neurosurg. 2019 Nov 1:1-2. doi: 10.3171/2019.7.JNS191780.
    PubMed    


    October 2019
  113. VOGELBAUM MA
    Editorial. Considering the role of surgery for low-grade glioma in the molecular genetic era.
    J Neurosurg. 2019 Oct 25:1-3. doi: 10.3171/2019.7.JNS191747.
    PubMed    


  114. KAVOURIDIS VK, Boaro A, Dorr J, Cho EY, et al
    Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.
    J Neurosurg. 2019 Oct 25:1-11. doi: 10.3171/2019.6.JNS19972.
    PubMed     Abstract available


  115. YOUNGBLOOD MW, Duran D, Montejo JD, Li C, et al
    Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
    J Neurosurg. 2019 Oct 25:1-10. doi: 10.3171/2019.8.JNS191266.
    PubMed     Abstract available


  116. SMITH N, Saunders D, Jensen RL, Towner RA, et al
    Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS182435.
    PubMed     Abstract available


  117. YOMO S, Oda K, Oguchi K
    Single- versus 2-session Gamma Knife surgery for symptomatic midsize brain metastases: a propensity score-matched analysis.
    J Neurosurg. 2019 Oct 18:1-9. doi: 10.3171/2019.7.JNS191193.
    PubMed     Abstract available


  118. IBRAHIM AN, Yamashita D, Anderson JC, Abdelrashid M, et al
    Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.
    J Neurosurg. 2019 Oct 18:1-12. doi: 10.3171/2019.7.JNS191376.
    PubMed     Abstract available


  119. SCHNEIDER M, Guresir A, Borger V, Hamed M, et al
    Preoperative tumor-associated epilepsy in patients with supratentorial meningioma: factors influencing seizure outcome after meningioma surgery.
    J Neurosurg. 2019 Oct 11:1-7. doi: 10.3171/2019.7.JNS19455.
    PubMed     Abstract available


  120. HANSEN RW, Pedersen CB, Halle B, Korshoej AR, et al
    Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.
    J Neurosurg. 2019 Oct 4:1-8. doi: 10.3171/2019.6.JNS191531.
    PubMed     Abstract available


  121. JARVIS CA, Bakhsheshian J, Ding L, Wen T, et al
    Increased complication and mortality among non-index hospital readmissions after brain tumor resection is associated with low-volume readmitting hospitals.
    J Neurosurg. 2019 Oct 4:1-13. doi: 10.3171/2019.6.JNS183469.
    PubMed     Abstract available


    September 2019
  122. MARHOLD F, Mercea PA, Scheichel F, Berghoff AS, et al
    Detailed analysis of 5-aminolevulinic acid induced fluorescence in different brain metastases at two specialized neurosurgical centers: experience in 157 cases.
    J Neurosurg. 2019 Sep 27:1-12. doi: 10.3171/2019.6.JNS1997.
    PubMed     Abstract available


  123. ZHU P, Du XL, Blanco AI, Ballester LY, et al
    Impact of facility type and volume in low-grade glioma outcomes.
    J Neurosurg. 2019 Sep 27:1-11. doi: 10.3171/2019.6.JNS19409.
    PubMed     Abstract available


    May 2019
  124. GUO X, Yao S, Xing B
    Letter to the Editor. Is 7-Tesla MRI necessary in the assessment of microstructural injury to visual pathways due to pituitary adenomas?
    J Neurosurg. 2019 May 17:1-3. doi: 10.3171/2019.2.JNS19413.
    PubMed    


    February 2019
  125. KO CC, Chen TY, Lim SW, Kuo YT, et al
    Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
    J Neurosurg. 2019 Feb 1:1-9. doi: 10.3171/2018.10.JNS181783.
    PubMed     Abstract available


    January 2019
  126. RUTLAND JW, Padormo F, Yim CK, Yao A, et al
    Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
    J Neurosurg. 2019 Jan 18:1-10. doi: 10.3171/2018.9.JNS182022.
    PubMed     Abstract available


  127. RINALDO L, Brown DA, Bhargav AG, Rusheen AE, et al
    Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    J Neurosurg. 2019 Jan 4:1-12. doi: 10.3171/2018.7.JNS181175.
    PubMed     Abstract available


    December 2018
  128. MUNIER SM, Hargreaves EL, Patel NV, Danish SF, et al
    Ablation dynamics of subsequent thermal doses delivered to previously heat-damaged tissue during magnetic resonance-guided laser-induced thermal therapy.
    J Neurosurg. 2018 Dec 21:1-8. doi: 10.3171/2018.7.JNS18886.
    PubMed     Abstract available



  129. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas.
    J Neurosurg. 2018 Dec 14:1-11. doi: 10.3171/2018.7.JNS181642.
    PubMed     Abstract available


    October 2018

  130. ReStNeuMap: a tool for automatic extraction of resting-state functional MRI networks in neurosurgical practice.
    J Neurosurg. 2018 Oct 1:1-8. doi: 10.3171/2018.4.JNS18474.
    PubMed     Abstract available


    September 2018
  131. MUHLESTEIN WE, Akagi DS, McManus AR, Chambless LB, et al
    Machine learning ensemble models predict total charges and drivers of cost for transsphenoidal surgery for pituitary tumor.
    J Neurosurg. 2018 Sep 21:1-10. doi: 10.3171/2018.4.JNS18306.
    PubMed     Abstract available


    May 2018
  132. LIN M, Wedemeyer MA, Bradley D, Donoho DA, et al
    Long-term surgical outcomes following transsphenoidal surgery in patients with Rathke's cleft cysts.
    J Neurosurg. 2018 May 18:1-7. doi: 10.3171/2017.11.JNS171498.
    PubMed     Abstract available


  133. WANG Z, Xing B
    Letter to the Editor. Detection of MRI-negative Cushing's disease by FLAIR imaging: is it reliable?
    J Neurosurg. 2018 May 4:1-2. doi: 10.3171/2017.12.JNS173041.
    PubMed    


    April 2018
  134. SIVAKUMAR W, Jensen M, Martinez J, Tanana M, et al
    Intravenous acetaminophen for postoperative supratentorial craniotomy pain: a prospective, randomized, double-blinded, placebo-controlled trial.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.10.JNS171464.
    PubMed     Abstract available


    March 2018
  135. LI D, Jiao YM, Wang L, Lin FX, et al
    Surgical outcome of motor deficits and neurological status in brainstem cavernous malformations based on preoperative diffusion tensor imaging: a prospective randomized clinical trial.
    J Neurosurg. 2018 Mar 16:1-16. doi: 10.3171/2017.8.JNS17854.
    PubMed     Abstract available


    December 2017
  136. MAYBERG M, Reintjes S, Patel A, Moloney K, et al
    Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    J Neurosurg. 2017 Dec 22:1-10. doi: 10.3171/2017.6.JNS17635.
    PubMed     Abstract available


    October 2017
  137. POMERANIEC IJ, Kano H, Xu Z, Nguyen B, et al
    Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
    J Neurosurg. 2017 Oct 27:1-10. doi: 10.3171/2017.5.JNS163069.
    PubMed     Abstract available


  138. CHATAIN GP, Patronas N, Smirniotopoulos JG, Piazza M, et al
    Potential utility of FLAIR in MRI-negative Cushing's disease.
    J Neurosurg. 2017 Oct 13:1-9. doi: 10.3171/2017.4.JNS17234.
    PubMed     Abstract available


    June 2017
  139. ESEONU CI, Eguia F, Garcia O, Kaplan PW, et al
    Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy.
    J Neurosurg. 2017 Jun 16:1-7. doi: 10.3171/2017.1.JNS162913.
    PubMed     Abstract available


    April 2017
  140. GESSLER F, Bruder M, Duetzmann S, Tritt S, et al
    Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors.
    J Neurosurg. 2017 Apr 7:1-7. doi: 10.3171/2016.11.JNS161871.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: